BR0207446A - Composição medicinal que contém diclofenaco e ornoprostil. - Google Patents

Composição medicinal que contém diclofenaco e ornoprostil.

Info

Publication number
BR0207446A
BR0207446A BR0207446-0A BR0207446A BR0207446A BR 0207446 A BR0207446 A BR 0207446A BR 0207446 A BR0207446 A BR 0207446A BR 0207446 A BR0207446 A BR 0207446A
Authority
BR
Brazil
Prior art keywords
ornoprostil
diclofenac
composition containing
medicinal composition
tablets
Prior art date
Application number
BR0207446-0A
Other languages
English (en)
Inventor
Yoshiki Sakai
Nobuo Katsube
Akio Nishiura
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of BR0207446A publication Critical patent/BR0207446A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO MEDICINAL QUE CONTéM DICLOFENACO E ORNOPROSTIL". Composições medicinais que contêm Diclofenaco ou seu sal não tóxico e Ornoprostil. Em comparação com tabletes de diclofenaco e tabletes de Arthrotec comercialmente disponíveis, espera-se que as composições acima que compreendem uma combinação de diclofenaco com Ornoprostil exerçam um efeito rápido com poucos efeitos colaterais (em particular, úlcera digestiva, diarréia/vómito e insuficiência renal) e tenham excelentes efeitos antipirético, analgésico e antiinflamatório.
BR0207446-0A 2001-02-22 2002-02-20 Composição medicinal que contém diclofenaco e ornoprostil. BR0207446A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001046430 2001-02-22
PCT/JP2002/001474 WO2002066030A1 (fr) 2001-02-22 2002-02-20 Compositions medicales contenant du diclofenac et de l'ornoprostil

Publications (1)

Publication Number Publication Date
BR0207446A true BR0207446A (pt) 2004-04-06

Family

ID=18908056

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207446-0A BR0207446A (pt) 2001-02-22 2002-02-20 Composição medicinal que contém diclofenaco e ornoprostil.

Country Status (16)

Country Link
US (1) US20040068014A1 (pt)
EP (1) EP1362588A1 (pt)
JP (1) JPWO2002066030A1 (pt)
KR (1) KR20030076692A (pt)
CN (1) CN1501798A (pt)
BR (1) BR0207446A (pt)
CA (1) CA2438241A1 (pt)
CZ (1) CZ20032256A3 (pt)
HU (1) HUP0304063A3 (pt)
IL (1) IL157451A0 (pt)
MX (1) MXPA03007487A (pt)
NO (1) NO20033709L (pt)
PL (1) PL365442A1 (pt)
RU (1) RU2003125876A (pt)
WO (1) WO2002066030A1 (pt)
ZA (1) ZA200306545B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060122275A1 (en) * 2002-08-22 2006-06-08 Yoshiki Sakai Agentfor reducing side effects of diclofenac
DK1978944T3 (da) 2006-01-24 2012-11-05 Sucampo Ag Blød-gelatine-kapselformulering
JP5054966B2 (ja) * 2006-12-20 2012-10-24 ロート製薬株式会社 固形製剤
CA2808610C (en) 2010-08-10 2018-09-25 R.P. Scherer Technologies, Llc Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
US20150238451A1 (en) * 2012-10-19 2015-08-27 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
CN108348616B (zh) * 2015-09-30 2022-12-23 株式会社大赛璐 易服用性固体制剂用颗粒组合物和包含该颗粒组合物的易服用性固体制剂
CN106798335A (zh) * 2017-01-10 2017-06-06 威海百合生物技术股份有限公司 中链甘油三酯的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578643A (en) * 1992-05-20 1996-11-26 Loyola University Of Chicago Protective prostaglandins for use in conjunction with chemotherapeutic agents
CA2277407A1 (en) * 1999-07-14 2001-01-14 Bernard Charles Sherman Pharmaceutical tablet comprising an nsaid and misoprostol

Also Published As

Publication number Publication date
ZA200306545B (en) 2004-11-22
IL157451A0 (en) 2004-03-28
EP1362588A1 (en) 2003-11-19
US20040068014A1 (en) 2004-04-08
CN1501798A (zh) 2004-06-02
CZ20032256A3 (en) 2004-03-17
NO20033709L (no) 2003-10-22
JPWO2002066030A1 (ja) 2004-06-17
NO20033709D0 (no) 2003-08-20
PL365442A1 (en) 2005-01-10
KR20030076692A (ko) 2003-09-26
WO2002066030A1 (fr) 2002-08-29
HUP0304063A2 (hu) 2004-04-28
CA2438241A1 (en) 2002-08-29
MXPA03007487A (es) 2003-12-08
RU2003125876A (ru) 2005-02-10
HUP0304063A3 (en) 2005-05-30

Similar Documents

Publication Publication Date Title
EE9700325A (et) Valitud lantaankarbonaathüdraate sisaldavad farmatseutilised kompositsioonid
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
BR0016555A (pt) Composições farmacêuticas que proporcionam concentrações acrescidas de droga
WO2004017998A3 (en) Topical emulsion- gel composition comprising diclofenac sodium
NO20062513L (no) Sammensetninger og doseringsformer for forsterket absorpsjon av metformin
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
ATE50433T1 (de) Pharmazeutische zusammensetzungen.
ATE234609T1 (de) Ibuprofen enthaltende schnelllösliche zusammensetzungen mit analgetischer wirkung
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
BR0207446A (pt) Composição medicinal que contém diclofenaco e ornoprostil.
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
DK1635651T3 (da) Fremgangsmåder for hyperthyreose hos en kat og sammensætning omfattende et begrænset indhold af iod
TW200744676A (en) Pharmaceutical compositions for the eradication of helicobacter pylori
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
UA42722C2 (uk) Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить
BRPI0410374A (pt) composição farmacêutica que compreende valsartano
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
DE60110814D1 (de) Zusammensetzungen mit langsamer freigabe enthaltend lithium-carbonat
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
BR0207762A (pt) Uso de um composto ou um sal farmaceuticamente aceitável do mesmo, combinação, formulação farmacêutica, kit, método para a prevenção da úlcera gástrica induzida por medicamento, e, composição farmacêutica oral
EP1547587A4 (en) AGENT USED TO REDUCE THE SIDE EFFECTS OF DICLOFENAC
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
BR9406629A (pt) Composições antiacidas liquidas
AR008764A1 (es) Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]

Free format text: REFERENTE A RPI NO 1864 DE 26/09/2006.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5O, 6O E 7O ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.